Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Gorf79on Jul 07, 2022 8:39am
156 Views
Post# 34807775

I Wonder…

I Wonder…

How Spectral will downplay their BREAKTHROUGH STATUS with the FDA?

Huh, that one might be tough to suppress and downplay.

Then again, they did come away unscathed after signing the ARC Dialysis deal. ARC happens to be the largest dialysis provider in the  South  Eastern US but nobody noticed the massively impressive win Spectral just accomplished.
 


A 33 person West Mall outfit desstroyed ENORMOUS industry rivals in landing the ARC deal!

On second thought maybe they will skate through a BTD approval without any negative damage like share price appreciation and increased US investor interest?

Huh!

<< Previous
Bullboard Posts
Next >>